Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress toward gene therapy.

R M Blaese1

  • 1Cellular Immunology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Clinical Immunology and Immunopathology
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The treatment of adenosine deaminase deficiency.

Immunology today·2014
Same author

A novel approach using transcomplementing adenoviral vectors for gene therapy of adrenocortical cancer.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2002
Same author

Biosynthetic ganciclovir triphosphate: its isolation and characterization from ganciclovir-treated herpes simplex thymidine kinase-transduced murine cells.

Biochemical and biophysical research communications·2001
Same author

AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits.

Gene therapy·2001
Same author

Development of a skin-based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes.

Gene therapy·2001
Same author

Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

Blood·2000
Same journal

Mechanisms of virus replication, persistence, and regulation of immune responses.

Clinical immunology and immunopathology·2020
Same journal

Cumulative subject index for volumes 86-89

Clinical immunology and immunopathology·1998
Same journal

D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.

Clinical immunology and immunopathology·1998
Same journal

Characterization of gastric Na+/I- symporter of the rat.

Clinical immunology and immunopathology·1998
Same journal

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

Clinical immunology and immunopathology·1998
Same journal

Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Clinical immunology and immunopathology·1998
See all related articles

Gene therapy aims to treat genetic diseases by targeting DNA. Research shifted from bone marrow stem cells to T lymphocytes, enabling treatments for rare genetic disorders and cancers.

Area of Science:

  • Genetics
  • Molecular Biology
  • Immunology

Background:

  • Genetic diseases represent a significant unmet medical need, with over 4000 identified conditions.
  • Traditional treatments are often ineffective for many debilitating or fatal genetic disorders.
  • Early gene therapy research focused on bone marrow stem cells for diseases like sickle cell anemia.

Purpose of the Study:

  • To review the historical development and evolution of gene transfer and gene therapy.
  • To explore alternative cellular targets beyond bone marrow stem cells.
  • To summarize the transition to clinical applications of gene therapy.

Main Methods:

  • Historical literature review.
  • Analysis of gene transfer techniques.

Related Experiment Videos

  • Evaluation of cellular targets for gene therapy.

    • Main Results:

    • Challenges in bone marrow stem cell biology led to alternative approaches.
    • Development of gene therapy techniques applicable to diverse diseases.
    • Identification of T lymphocytes as a promising cellular alternative.

    Conclusions:

    • Gene therapy has evolved beyond initial concepts for bone marrow disorders.
    • New strategies enable treatment of both rare genetic and common non-genetic diseases like cancer.
    • T lymphocyte-based gene therapy represents a significant advancement in clinical applications.